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In Brief
Most resident macrophages originate
from fetal sources and then self-renew in
situ tomaintain their numbers through the
lifetime of the mouse. Karjalainen and
colleagues show here that most resident
macrophages, brain microglia excluded,
are descendants of fetal hematopoietic
stem cells and not from yolk sac
precursors as suggested previously.
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Macrophages are one of the most diverse cell popu-
lations in terms of their anatomical location and
functional specialization during both homeostasis
and disease. Although it has been shown in different
fate mapping models that some macrophages pre-
sent in adult tissues are already established during
fetal development, their exact origins are still un-
der debate. In the current study, we developed a
fate mapping strain, based on the Kit locus, which
allowed us to readdress ‘‘the origins’’ question.
Different types of macrophages from various adult
tissues were traced to their fetal or adult sources
by inducing labeling in precursors at several time
points either during fetal development or in adult
mice. We show that all adult macrophages, resident
or infiltrating, are progenies of classical hematopoi-
etic stem cells (HSC) with the exception of microglia
and, partially epidermal Langerhans cells, which are
yolk sac (YS)-derived.
INTRODUCTION
Ilya Mechnikov was the first to describe macrophages in the
late 19th century as large phagocytic cells (macro ‘‘big’’ + phage
‘‘eat’’). Although these features are common to all macrophages,
these cells exhibit high plasticity in terms of their functional diver-
sity. They have important roles in organ development, tissue
homeostasis and repair, in addition to their roles as effectors of
innate immunity (Wynn et al., 2013). Macrophages are tradition-
ally defined and categorized by their anatomical territory. Exam-
ples include brain microglia, liver Kupffer cells and lung alveolar,
splenic red pulp, and peritoneal macrophages.
The established concept of the mononuclear phagocytic
system (MPS) has been used to unify such a diverse cell type
as one functional entity. According to this concept, monocytes
developing in the bone marrow (BM) continuously colonize
different tissues and mature into macrophages in situ. However,
this concept has been challenged recently and thought to be an
oversimplification. The first evidence that tissue macrophages
can develop from embryonic sources and bypass monocytic in-
termediates came frommicroglia-resident macrophages in brain382 Immunity 43, 382–393, August 18, 2015 ª2015 Elsevier Inc.parenchyma. Based on the Runx1MercreMer fate mapping mouse,
microglia were shown to be derived from embryonic day 7.5
(E7.5) yolk sac (YS) precursors (Ginhoux et al., 2010). Further-
more, based on Csf1rMercreMer fate mapping mouse, YS origin
was generalized tomanymacrophages in other tissues including
epidermis, liver, spleen, lung, pancreas, and kidney (Schulz
et al., 2012). In a study from Schulz et al., the authors noted
that tissue macrophages can consist of different pools of cells
based on F4/80 and CD11b expression: F4/80hi macrophages
were postulated to be derived from YS precursors that were
able to maintain their numbers in situ (resident), while CD11bhi
macrophages were thought to be replaced continuously by
BM-generated monocytes (infiltrating) (Schulz et al., 2012). In
a subsequent study, F4/80hi resident macrophages were pro-
posed to originate from YS-derived erythro-myeloid progenitors
(EMPs) (Gomez Perdiguero et al., 2015).
Although the prenatal origin and local maintenance of F4/80hi
tissue macrophages were confirmed by other studies (Hashi-
moto et al., 2013; Yona et al., 2013), conflicting reports have
also been put forward suggesting a different origin for F4/80hi
tissue macrophages. For example, Langerhans cells (LCs)
were reported to originate from YS precursors by Schulz et al.
(2012), whereas Hoeffel et al. (2012) reported that they originated
predominately from fetal liver (FL) monocytes. Similarly, lung
alveolar macrophages were shown to originate from YS progen-
itors by Schulz et al. (2012), but two other studies found that they
originated from fetal monocytes via a granulocyte macrophage
colony stimulating factor (GM-CSF)-dependent pathway (Guil-
liams et al., 2013; Schneider et al., 2014) with minimal contribu-
tion from BM (Hashimoto et al., 2013).
Althoughmicroglia are commonly accepted to be derived from
YS precursors (Epelman et al., 2014; Ginhoux et al., 2010; Kier-
dorf et al., 2013; Gomez Perdiguero et al., 2015; Schulz et al.,
2012), the nature of these precursors has been debated. In one
fate mapping study usingRunx1MercreMer mice, YSmicroglia pre-
cursors were already labeled at embryonic day 7–7.25 (E7–7.25)
(Ginhoux et al., 2010), while in the Csf1rMercreMer fate mapping
model, precursors were only labeled starting at E8.5 and were
suggested to represent EMPs (Bertrand et al., 2005b; Kierdorf
et al., 2013; Gomez Perdiguero et al., 2015). Thus the origins of
tissue macrophages remain unclear.
There are several limitations to the inducible fate map-
ping models currently available to study ontogenesis of tissue
macrophages, including the Runx1MercreMer, Csf1rMercreMer,
and Cx3cr1creER mouse models (Ginhoux et al., 2010; Kierdorf
et al., 2013; Gomez Perdiguero et al., 2015; Yona et al.,
2013). Runx1 expression is required for the very early event of
endothelial to hematopoietic cell transition, but not thereafter
(Chen et al., 2009). Thus, Runx1 expression is transient during
early embryonic development and cannot be used to ‘‘tag’’ late
precursors (Lacaud et al., 2002). Csf1r- and Cx3cr1-inducible
fate mapping models also target macrophage progenitors
and mature macrophages, complicating the interpretation of
results.
Because Kit (CD117) is expressed in early YS and FL progen-
itors as well as in fetal and adult HSCs and their early progenies,
but not in mature hematopoietic cells (Ivanova et al., 2002), we
have generated a KitMercreMer mouse strain that allowed us to
fate map with a different approach, adult macrophages and
myeloid cells in various tissues at different time points of
ontogeny. We show that all adult macrophages, resident and
infiltrating, are derived from definitive hematopoiesis like neutro-
phils and lymphocytes. Exceptions include brain microglia and
partially also epidermal Langerhans cells (LCs) that are descen-
dants from YS precursors.
RESULTS
Generation of KitMercreMer Mouse and Strategy for Fate
Mapping
In order to fate map the descendants of hematopoietic precur-
sors from early embryonic, fetal, or adult stages, we generated
a mouse strain containing an inducible MercreMer construct
inserted into the 30-UTR of the Kit gene, hereafter called
KitMercreMer (Figure S1A). This insertion did not affect the expres-
sion of CD117 in BM cells (data not shown) and the crosses be-
tween KitMercreMer (BALB/c) and Rosa26-loxP-STOP-loxP-eYFP
(C57BL/6) strains (KitMercreMerR26) could then be used as adults
or as timed pregnancies for fate mapping. We gave single
tamoxifen injections at different time points during gestation
(E7.5, E8.5, E9.5, E11.5, E13.5, E15.5, or E17.5) or multiple injec-
tions during a 1-month period in adult mice to induce YFP label-
ing, which was then scored in different myeloid cells in embryos
or in adult mice (Figure S1B). Importantly, short-lived peripheral
blood neutrophils, T cells, and B cells were used as convenient
internal control populations that reflect the activity of HSC and
their primitive progenies. To increase rigor of analysis, we took
comparative results of different tissues at a given time point
from the same mouse as the peripheral blood neutrophils and
lymphocyte controls.
Most Tissues Contain Three Phenotypically Similar
Pools of Myeloid Cells
To identify target cells for fate mapping, we analyzed CD45+
cells for CD11b and F4/80 expression using colonic lamina
propria cells as a guide. Three major populations could be
observed: F4/80hi CD11bhi (Fr I), F4/80int CD11bhi (Fr II), and
F4/80lo CD11bhi (Fr III) cells (Figure 1). To further characterize
the fractions, we analyzed them for macrophage markers
defined by the recent Immunological Genome (ImmGen) Proj-
ect (Gautier et al., 2012), including CD64, CD16/32, MerTK,
and transgenic Cx3cr1GFP/+ expression (core macrophage sig-
natures). Using these criteria, the cells in Fr I belonged to
macrophages corresponding to the so-called F4/80hi resident
cells (Schulz et al., 2012). In addition, these macrophageswere CD11c+ MHC II+ and typically represented a homogenous
population (Figure 1).
Fr II cells were further characterized based on Ly6C and MHC
II expression (Tamoutounour et al., 2012; Jakubzick et al., 2013).
At least four different cell subpopulations were delineated:
Ly6Chi MHC IIlo to hi (IIa), Ly6Cint MHC IIhi (IIb), Ly6Clo MHC IIhi
(IIc), and Ly6Clo MHC IIlo (IId). The phenotypes of cells in the
IIa, IIb, and IIc sub-fractions suggested them to be monocytic
and macrophage lineage cells with increasing maturity from IIa
to IIc. A similar maturation cascade has also been observed in
recent reports (Bain et al., 2014; Tamoutounour et al., 2013).
The most abundant sub-fraction in the colon, IId, consisted of
eosinophils as shown by Siglec-F and CCR3 expression but
very low CD117 expression (Figure 1). Fr III (F4/80lo CD11bhi)
cells appeared to represent typical neutrophils, as suggested
by their Ly6Ghi Ly6Cint phenotype (Figure 1).
The same three major fractions found in the colon could be
identified in most tissues examined (Table S1A), including the
brain, colon, peritoneum, liver, kidney, spleen, lung, and dermis,
although the relative expression of CD11b and F4/80 varied in
different tissues (Figure 2). For example, Fr I F4/80hi CD11blo
cells in the lung appeared to be alveolar macrophages as they
were the major cell type in bronchoalveolar lavage (BAL) fluid,
while Fr I macrophages in the peritoneum were F4/80hi CD11bhi
(Figure 2). The epidermis almost entirely consisted of macro-
phages (Fr I, LCs) with hardly any detectable Fr II (monocytes,
macrophages, and eosinophils) or Fr III (neutrophils) (Figure 2).
Classically-defined tissue resident macrophages such as
Kupffer cells, alveolarmacrophages, and spleen red pulpmacro-
phages belonged to Fr I (F4/80hi), thus ‘‘Fr I phenotype cells’’ in
other organs most likely represent resident macrophages (Ha-
shimoto et al., 2013).
Fr I resident macrophages typically represented a homoge-
nous population as revealed by CD11c and MHC II staining.
However, an exception to this was noted in Fr I cells of the dermis
where two separate MHC IIlo and MHC IIhi macrophage popula-
tions were observed (Figure 2). Similar populations have been
reported in an independent study based on CCR2 and CD64
staining (Tamoutounour et al., 2013).
The relative representation of sub-fractions (monocytes, mac-
rophages, and eosinophils) in the Fr II population varied between
different tissues. For example, the colon had a dominant eosin-
ophil population, whereas the kidney had a dominant monocyte
subpopulation (Figure 2). The peritoneal Fr II population con-
sisted mainly of mature macrophages (Fr II c). It is very likely
that peritoneal MHC IIlo Fr I (F4/80hi) cells represented Gata6-
dependent macrophages while MHC IIhi Fr II cells represented
Gata6-independent macrophages (Okabe and Medzhitov,
2014; Rosas et al., 2014), originally described by Ghosn et al.
(2010).
Neutrophils (Fr III) typically represented a minor population in
tissues with the exception of the brain and lung where steady-
state neutrophils were abundant, probably representing large
marginated pools (Hogg and Doerschuk, 1995; Summers et al.,
2010). Of note, brain Fr I cells (microglia) were CD45int and could
therefore be separated from CD45hi Fr II and III cells that repre-
sented perivascular populations (Aloisi et al., 2000). Further
characterization of perivascular Fr III cells clearly showed them
to be classical neutrophils (Figure S2).Immunity 43, 382–393, August 18, 2015 ª2015 Elsevier Inc. 383
Figure 1. Characterization of Myeloid Cell Subsets as Targets for Fate Mapping
Gating and staining strategy exemplified with colon lamina propria cells: After gating out CD11chi MHC IIhi DCs, CD45+ cells comprised three major myeloid cell
fractions: F4/80hi CD11bhi cells (Fr I), F4/80int CD11bhi (Fr II), and F4/80lo CD11bhi (Fr III). Fr I cells were MHC II+ CD11c+ and positive for several core macrophage
signaturemarkers, including CD64, CD16/32, MerTK, and CX3CR1. Ly6C andMHC II staining divided the Fr II cells into at least four sub-fractions. Ly6C
MHC II
cells (Fr II d) are classical eosinophils (Siglec-F+ CCR3+ CD117). Ly6Chi MHC II to hi cells (Fr II a) are monocytes. Ly6C MHC IIhi cells (Fr II c) are typical
macrophages; i.e., positive for macrophage signature markers tested except MerTK. Fr II b cells were positive for macrophage signature markers but had
intermediate expression of Ly6C and CX3CR1. Fr III cells were typical Ly6G
hi Ly6Cint neutrophils. Data are representative of ten mice.CD11bhi Infiltrating Cells Are Derived from BM, while
F4/80hi Resident Macrophages Have Pre- or Post-Natal
Origins
Because peripheral blood neutrophils are short-lived and
constantly replaced by HSC-dependent BM progenitors, we
used the labeling efficiency of peripheral blood neutrophils as
a reference in our fate mapping experiments where label was
induced in adult cells of KitMercreMerR26 mice (Figure S1B). In
the colon, neutrophils (Fr III) labeled to a similar degree as pe-
ripheral blood neutrophils, as was the case for all sub-fractions
of CD11bhi cells (Fr II), indicating that these cells were gener-
ated from adult BM progenitors (Figure 3A and Figure S3).
Similar results were obtained with the same fractions from all
the tissues examined (Table S1B). The percentage of DC label-
ing was also similar to that of peripheral blood neutrophils
(Figure S4).
The labeling index of adult F4/80hi tissue-resident macro-
phages (Fr I) differed by tissue (Figures 3A and 3C). Brain micro-
glia, liver Kupffer cells, epidermal Langerhans cells, lung alveolar384 Immunity 43, 382–393, August 18, 2015 ª2015 Elsevier Inc.macrophages, and spleen red pulp macrophages were no
longer labeled when tamoxifen was administered at the adult
stage, while kidney and dermis MHC IIlo macrophages were
only labeled to a small degree. The above results suggested
that these macrophage populations were derived from earlier
precursors that could not be ‘‘tagged’’ in adult mice. Colon, peri-
toneum, and dermis MHC IIhi F4/80hi Fr I macrophages were
labeled after the adult injection regimen to a similar amount as
peripheral blood neutrophils (Figures 3A and 3C), indicating their
BM origin. Because the absolute labeling percentage in periph-
eral blood neutrophils varied in individual mice, but the relative
labeling of peripheral blood neutrophils to other cell populations
was constant regardless of the absolute labeling of peripheral
blood neutrophils (Figure S3), we normalized the labeling inten-
sities to that of peripheral blood neutrophils to minimize the un-
avoidable variation in absolutemarking after tamoxifen injections
between mice (Figures 3B and 3D).
Our results confirmed previous reports that intestinal and
dermal MHC IIhi F4/80hi macrophages originate from BM
Figure 2. Three Common Cell Fractions
Can Be Found in Most Tissues
The identification of three major cell fractions
(Fr I, II, and III) in brain, lung, liver, kidney, spleen,
peritoneum, and skin (dermis and epidermis)
according to the strategy adopted in Figure 1 is
shown. Brain myeloid cells were first gated in
CD45int cells, corresponding to microglia cells,
and CD45hi perivascular cells (upper panel).
Epidermal Langerhans cells were defined as Fr I
cells that were strongly positive for EpCAM and
MHC II. Data are representative of ten mice. See
also Figure S2.
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Figure 3. Fate Mapping of Adult BM Progenitors Predicts the Presence of Different Precursor Sources for Myeloid Cells
Adult fate mapping was performed as per Figure S1B and gating as per Figures 1 and 2. Peripheral blood neutrophils acted as internal controls for labeling
efficiency, and the tracings shown are from the same mouse for (A) and (C).
(A) Colonmyeloid cells as examples. Fr I macrophages, all Fr II subpopulations (F4/80int CD11bhi, infiltrating cells) and tissue neutrophils were labeled to the same
degree as peripheral blood neutrophils. Data are representative of eight mice. See also Figure S3.
(B) Labeling efficiency of colon myeloid cells was normalized to peripheral blood neutrophils. Data represent means ± SEM of eight mice.
(C) Labeling of tissue-resident macrophages. Brain microglia, epidermal LCs, Kupffer cells, lung alveolar macrophages, and spleen red pulp macrophages were
not labeled. Kidney and MHC IIlo dermal resident macrophages were partially labeled. Resident macrophages in the colon, peritoneum, and MHC IIhi dermal
resident macrophages were labeled to the same degree as peripheral blood neutrophils. Data are representative of eight mice.
(D) Labeling efficiency of tissue-resident macrophages (Fr I) in other tissues was normalized to peripheral blood neutrophils. Data represent means ± SEMof eight
mice. See also Figures S1 and S3–S6.monocytes (Bain et al., 2014; Rivollier et al., 2012; Tamoutounour
et al., 2013; Zigmond and Jung, 2013). However, as discussed
below, our observations regarding the turnover of adult perito-
neal macrophages disagree with previous studies that suggest
they form a local, autonomously maintained population (Hashi-
moto et al., 2013; Yona et al., 2013). We did not observe any
neutrophilia in the peritoneum (Figure S5), which excludes
inflammation as a cause for macrophage turnover. In addition,
peritoneal B1 cells were hardly tagged by adult tamoxifen treat-
ment as would be expected (Figure S5). To further substantiate
the importance of a continuous supply of BM to peritoneal mac-
rophages, we gave a single large tamoxifen pulse at the adult
stage and monitored the appearance of the labeled cells in
BM, blood, and peritoneum. Labeled peritoneal macrophages
were first detected at day 5 preceded by the appearance of
the label in BM and blood neutrophils, strongly suggesting that
peritoneal resident macrophages are derived from adult BM
monocytes (Figure S6).386 Immunity 43, 382–393, August 18, 2015 ª2015 Elsevier Inc.Peripheral blood T andB cells contained a lower percentage of
label than peripheral blood neutrophils, reflecting the long half-
lives of T and B cells. Large cohorts of unlabeled T and B cells
were able to develop prior to the first adult tamoxifen injection
(first injection at 6 weeks) thereby diluting the labeling percent-
age of newly generated blood lymphocytes (Figure S3).
Early YS Precursors Contribute to Adult Microglia and
Langerhans Cells
Because many lineages of tissue-resident macrophages cannot
be traced into adult BM progenitors, their precursors must
have been present during earlier stages of hematopoiesis. Early
YS precursors can be tagged in the Runx1MercreMer system (Gin-
houx et al., 2010). Therefore, we wanted to test whether these
early YS precursors can also be labeled in our system in order
to study their contribution to resident macrophage populations.
To do this, we gave a single injection of tamoxifen at E7.5 to
label KitMercreMerR26 embryos and measured the percentage of
A B
C
Figure 4. Fate Mapping of Embryonic Pre-
cursors Identify Adult Progenies from Two
Hematopoietic Waves
(A) A single injection of tamoxifen was given
at E7.5, E8.5, or E9.5 (Figure S1B) to label
KitMercreMerR26 embryos and the percentage of
labeled tissue-resident Fr I cells was measured at
6 weeks of age for microglia, epidermal LCs, liver
Kupffer cells, lung alveolar cells, spleen red pulp
macrophages, and resident macrophages of the
kidney, dermis, colon, and peritoneum. Peripheral
blood neutrophils were used as internal controls.
Gating was performed as shown in Figures 1 and
2. The tracings shown are from the samemouse at
the indicated time point of tamoxifen injection.
(B) Bars represent means ± SEM of four to seven
mice for each time point.
(C) YFP labeling efficiency of peripheral blood T
and B cells are shown. Data represent means ±
SEM of four to seven mice for each time point. See
also Figure S1.labeling in different resident macrophage populations in 6-week-
old adult mice (Figure S1B).
Consistent with earlier studies with the Runx1MercreMer mouse
(Ginhoux et al., 2010), we could label adult microglia with high ef-
ficiency (>50%). All other tissue-resident macrophages including
alveolar, kidney, spleen red pulp, dermal, and Kupffer cell popu-
lations labeled very poorly, similarly as control peripheral blood
neutrophils and T and B cells (1%–3%). The only exception
were LCs, which showed clear labeling (10%), suggesting
that later waves of precursors had diluted the original ‘‘50%
labeled population’’ (cf. microglia) (Figure 4). These results are
in good agreement with a previous report (Hoeffel et al., 2012),
showing that LCs are only partially derived from YS precursors.Immunity 43, 382–393Most Adult Resident Macrophages
Are Derived from a Second Wave
of Hematopoiesis Driven by
Classical HSCs
Definitive (HSC-producing) hematopoie-
sis starts at approximately E8.5 at the
para-aortic splanchnopleura (PSp) that
develops in the aorta-gonad-meso-
nephros (AGM). From here, cohorts of
HSCs later (at E10.5) colonize the fetal
liver (FL) where they undergo expansion
and early differentiation (Cumano and
Godin, 2007). To capture this and
ongoing YS waves, we injected a single
dose of tamoxifen at E8.5 or E9.5 to
induce YFP label in KitMercreMerR26 em-
bryos and again scored the percentage
of labeling in resident macrophages,
control peripheral blood neutrophils, and
lymphocytes in 6-week-old adult mice
(Figure S1B).
We could induce the label in adult
microglia as efficiently at E8.5 or E9.5
(50%) as at E7.5. Because blood circu-
lation is established around E9.5, which isessential for microglia seeding (Ginhoux et al., 2010), the same
population of YS precursors was labeled over the 3 day period
and therefore no dilution of microglia label by later precursors
was detected (and see below). These findings are consistent
with the combined results of previous studies using either
Runx1MercreMer or Csf1rMercreMer fate mapping mice (Ginhoux
et al., 2010; Kierdorf et al., 2013; Gomez Perdiguero et al.,
2015; Schulz et al., 2012).
Unlike adult microglia, which displayed similar percentages of
labeling after injection of tamoxifen at E7.5, 8.5, or 9.5, all other
resident macrophages and control peripheral blood neutrophils
and lymphocytes showed dramatically different labeling ki-
netics and could not be labeled with a tamoxifen pulse at E7.5., August 18, 2015 ª2015 Elsevier Inc. 387
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Figure 5. Early Embryonic Fate Mapping
Labels YS EMPs and AGM Precursors with
Different Kinetics
After a single pulse of tamoxifen at E7.5 or E8.5 to
label KitMercreMerR26 embryos, YS and AGM were
analyzed at E10.5.
(A) YS EMPs and AGM MPPs were first gated on
the kit+ CD45lo population, the majority of which
was Sca-1+. AA4.1 was used to further identify
both populations.
(B and C) YFP+ YS EMPs and AGMMPPs analyzed
at E10.5 after E7.5 or E8.5 tamoxifen pulse.
Representative plots are shown in (B), and data
from (C) represent means ± SEM of six embryos in
each group. See also Figure S1.However, after an E8.5- or 9.5-pulse of tamoxifen, all non-micro-
glial adult macrophages, together with peripheral blood neutro-
phils and lymphocyte controls, reached a similar robust labeling
index (40%).
We refer to this pattern as an HSC wave because the kinetics
of labeling coincide with the appearance of HSCs and also,
importantly, because many cell types (peripheral blood neutro-
phils, lymphocytes, and macrophages) representing the typical
adult output of HSCs shared a similar labeling intensity. Notably,
the labeling index of LCs (as mentioned above) increased from
10% at E7.5 to 60% at E8.5 or 9.5 (not to 40% as seen
for the other cells). This, indeed, suggests that LCs are descen-
dants from two sources, HSC and YS waves.
Early Fetal Fate Mapping Reveals the Progenitors of YS
and HSC Waves
In order to identify the potential progenitors responsible for YS
and HSC waves, we induced tagging in KitMercreMerR26 em-
bryos at E7.5 or E8.5 and scored the labeling index at E10.5
in YS and AGM progenitors (Figure 5). We used conventional
markers to identify EMPs in YS and AGM multipotent progeni-
tors (MPPs) as CD45lo Kithi Sca-1+AA4.1+ cells (Figure 5A). Of
note, the AA4.1+ portion of Kit+ Sca-1+ cells were larger for
AGMs, in good agreement with a previous study (Bertrand388 Immunity 43, 382–393, August 18, 2015 ª2015 Elsevier Inc.et al., 2005a). Induction at E7.5 lead to
robust labeling of YS EMPs (70%),
similar to that induced by the E8.5 pulse
(Figure 5B). Because we can robustly
label YS EMPs with the E7.5 tamoxifen
pulse, but not adult resident macro-
phages other than microglia, our results
strongly suggest that EMPs are not the
source of adult resident macrophages
as proposed previously (Gomez Perdi-
guero et al., 2015).
AGM MPPs could not be labeled with
the E7.5 pulse and were only labeled later
at E8.5 (Figure 5B). This is consistent with
the appearance of the first HSCs and their
progenies in the AGM region at this time
(Cumano and Godin, 2007). In addition,
the E8.5 pulse is the earliest pulse that
is able to induce strong labeling of adultresident macrophages, underlining the role of the HSC wave
as their potential source.
Since YS and AGM precursors migrate to the FL to expand
and further differentiate (Cumano and Godin, 2007; Palis
et al., 1999), we wanted to see whether we could discriminate
the descendants of YS and HSC waves in the FL by their label-
ing kinetics. To do this, label was induced in KitMercreMerR26
embryos at E7.5 or E8.5 and the amount of tagging was then
scored at E13.5 or E16.5 in FL myeloid cells as defined earlier
(Figure 6A).
In FL, we were able to identify neutrophils (Fr III, Ly6G+), pop-
ulations of monocytes (Fr IIa, Ly6C+), and eosinophils (Fr IId,
Ly6CSiglec-F+), both of which were MHC II-negative, and resi-
dentmacrophage-like cells (Fr I) (Figure 6A). Again, as in the case
of the AGM fate mapped cells, we could not induce labeling with
an E7.5 pulse in FL neutrophils (N), eosinophils (E), or monocytes
(M), although YS EMPs were strongly tagged (Figures 5A and
6B). In fact, NEMs could only be labeled 1 day later at E8.5
(Figure 6B).
However, FL Fr I macrophages (probably direct migrants from
YS) could be strongly tagged at E7.5 and these ‘‘early’’ labeled
cells were diluted by latecomers into the FL (45% E13.5 to
10% E16.5), and even more so in adults (1%–3%) (Figures
6B and 3).
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These FL tracing results support our conclusion that the HSC
wave, originating from AGM, is the source of adult resident mac-
rophages, and not YS EMPs, which contribute only to microglia
and partially to LCs. In addition, FL monocytes that were first
labeled at E8.5 could be the crucial intermediates for adult tissue
resident macrophages and in fact, Hoeffel et al. showed very
recently that FL monocytes can replace earlier YS-derived mac-
rophages in most tissues (Hoeffel et al., 2015).
Different Tissue Resident Macrophages Show
Characteristic Recruitment Windows
Because most adult tissues have stopped recruiting new resi-
dent macrophages (adult fate mapping), we wanted to study
how long the new resident macrophages first initiated at E8.5
by the HSC wave continued to be recruited into tissues. To do
this, we induced the YFP label in KitMercreMerR26 embryos at
E11.5, 13.5, 15.5, or 17.5 when the FL has become the dominant
source of hematopoiesis and then scored the labeling of resident
macrophages in adult mice (Figure 1B). The amount of induced
label in peripheral blood neutrophils was again used as a control
because FL HSC or their primitive progenitors colonize the BM
where they generate what will eventually become peripheral
granulocytes and lymphocytes in adults.
Microglia, which are derived from early YS precursors, are not
labeled at any of the above time points (Figure 7), which is
consistent with previous reports that exclude a contribution
from definitive hematopoiesis (Epelman et al., 2014; Ginhoux
et al., 2010; Kierdorf et al., 2013; Gomez Perdiguero et al.,
2015; Schulz et al., 2012). Most resident tissue macrophages
were labeled to similar amount as peripheral blood neutrophils
by the E11.5 pulse, however, when tamoxifen was injected at
E13.5, 15.5, or 17.5, clear differences were detected in the
labeling efficiency of F4/80hi macrophages from different tissues
(Figure 7A). Three trends could be observed (Figure 7B): Labeling
percentage gradually decreased to zero in some tissue macro-
phages such as Kuppfer cells, LCs, alveolar macrophages,
and spleen red pulp macrophages (Trend I). For kidney and
dermis MHC IIlo F4/80hi macrophages, labeling efficiency
decreased but was then maintained at a lower level (Trend II).
For colon, peritoneum, and dermis MHC IIhi F4/80hi macro-
phages, labeling efficiency was similar to peripheral blood
neutrophils across all time points (Trend III). Our results confirm
the fetal origins of most resident macrophages. However, our
findings strongly suggest the fetal hematopoietic stem cells
and not the YS-derived precursors as a source for these cells.
DISCUSSION
In order to identify targets for our fate mapping experiments, we
initially refined the characterization of myeloid cells in several
different tissues. In almost all tissues analyzed (excluding the
epidermis, dermis, and peritoneum), we can identify three major
populations of myeloid cells (excluding DCs) based on CD11b
and F4/80 expression, with some minor variations: F4/80hiFigure 6. Progenies of Two Hematopoietic Waves Can Be Detected in
(A) The gating strategy for characterization of FL myeloid cells, which follows the
(B) After a single pulse of tamoxifen at E7.5 or E8.5, as indicated, microglia and feta
left and the combined data on the right represent means ± SEM of three to six e
390 Immunity 43, 382–393, August 18, 2015 ª2015 Elsevier Inc.resident macrophages (Fr I), CD11bhi infiltrating cell mixtures
(Fr II), and neutrophils (Fr III). CD11bhi cells consist of a mixture
of monocytes, macrophages, and eosinophils. The composition
of CD11bhi cell mixtures varied slightly across different tissues
e.g., the colon has a major eosinophil fraction, while the kidney
has an abundant monocyte population.
Adult fatemapping showed that all infiltratingCD11bhi cell mix-
tures (Fr II) and neutrophils (Fr III), in all tissues tested, became
labeled to a similar extent as peripheral blood neutrophils, sug-
gesting that adult BM HSC or primitive long-lived progenitors
are the source of these cells. However, tissue-resident macro-
phages, i.e., F4/80hi (Fr I) cells, namely brain microglia, liver
Kuppfer cells, epidermal LCs, and spleen red pulp, lung alveolar,
andmost of the kidney, behaved differently, and dermal MHC IIlo
macrophages could not be induced to carry label after adult
tamoxifen pulses because their origins are from prenatal precur-
sors (further discussed below). Colonic, dermal MHC IIhi, and
peritoneal macrophages labeled in a similar manner to peripheral
blood neutrophils, suggesting a high turnover and continuous
supply from adult BM. These results confirmed previously re-
ported observations that intestinal and dermal MHC IIhi F4/80hi
macrophages originate from BM monocytes (Bain et al., 2014;
Rivollier et al., 2012; Tamoutounour et al., 2013; Zigmond and
Jung, 2013). However, peritoneal macrophages were thought
to represent a self-renewing, autonomous local pool (Hashimoto
et al., 2013; Yona et al., 2013), which is in disagreement with our
results. In the adult fate mapping study of Yona et al. using
Cx3cr1creER mice, peritoneal macrophages were not labeled,
which is the opposite of what we would have expected because,
according to our observations, their monocyte precursors were
CX3CR1-positive. In their study, only tissue macrophages that
were themselves strongly CX3CR1-positive were labeled in
Cx3cr1creER mice. However, the authors did not show whether
they could label other monocyte-dependent CX3CR1-negative
macrophages (as positive controls), e.g., dermal MHC IIhi cells,
in Cx3cr1creER mice to validate the robustness of their approach
under steady-state conditions (Yona et al., 2013). The authors
also showed that under inflammatory conditions, monocytes
were recruited into the peritoneum where they became MHC
IIhi macrophages that later developed into MHC IIlo cells. How-
ever, under normal conditions, 1%–10% of peritoneal macro-
phages are in fact MHC IIhi (Okabe and Medzhitov, 2014; Rosas
et al., 2014; Ghosn et al., 2010), so we could argue that steady-
state MHC IIlo macrophages are also derived from infiltrating
monocytes via transitional MHC IIhi macrophages. In addition,
the parabiosis data of Hashimoto et al. speak clearly for self-
renewing peritoneal macrophages although some of their fate
mapping results could also support the idea of partial contribu-
tion from adult BM. The discrepancy between their and our find-
ings could be explained by the differences in mouse strains
C57BL/6 versus (BALB/c 3 C57BL/6) F1 or their housing condi-
tions that can certainly have influence in this compartment.
Our major finding that all tissue-resident macrophages,
except brain microglia and to some extent, epidermal LCs, areFetal Liver
conventions of Figure 2, is shown.
l liver were analyzed at E13.5 and E16.5. Representative plots are shown on the
mbryos in each group. See also Figure S1.
AB
Figure 7. Characteristic Recruitment Windows for Different Tissues
Tamoxifen was given at E11.5, E13.5, E15.5, or E17.5 to label KitMercreMerR26
embryos using the experimental scheme shown in Figure 4.
(A) Data are representative of five to ten mice for each time point. Plots
corresponding to a given time point, were from the same mouse.
(B) Graphical representation of the normalized labeling efficiency (with
peripheral blood neutrophils) of different tissues across different time points
shows three major trends, indicated in different colors. Data represent
means ± SEM with five to ten mice in each group. See also Figure S1.generated by definitive intra-embryonic hematopoiesis chal-
lenges the view that most tissue-resident adult macrophages
are derived from extra-embryonic YS precursors defined as
EMPs (Gomez Perdiguero et al., 2015; Schulz et al., 2012). Our
strongest evidence against the ‘‘EMP hypothesis’’ is that
although we could strongly label YS EMPs (E10.5) by inducing
tagging in KitMercreMerR26 embryos at E7.5, we were not able
to detect any clear tagging in adult tissue-resident macro-
phages, except microglia and some LCs. Similarly, FL mono-
cytes, neutrophils, or eosinophils (E13.5 and 16.5) remained
unlabeled. Yet, a tamoxifen pulse, 1 day later at E8.5, labeled
all adult non-microglial tissue-resident macrophages to the
same extent as peripheral blood neutrophils and lymphocytes
(apart from LCs which were labeled to a greater extent). In addi-
tion, the E8.5 pulse also labeled FL monocyte, neutrophil, and
eosinophil populations efficiently. For simplicity, we refer to the
emergence of labeled cells after the E8.5 pulse as an HSC
wave because the timing corresponds to the beginning of defin-
itive HSC-dependent hematopoietic activity in the AGM region of
the embryo with a similar labeling index of many different cellular
types (macrophages, neutrophils, and lymphocytes) reflecting
the output of classical HSCs.
Themain thrust of Gomez Perdiguero et al. that YS EMPswere
the source of adult tissue-resident macrophages was the exploi-
tation of Csf1rMercreMer fate mapping mice (Gomez Perdiguero
et al., 2015). A pulse of tamoxifen at E8.5 in these mice induced
label at a later stage in YS and FL EMPs and also in FL hemato-
poietic progenies; however, due to low labeling frequency of
adult tissue-resident macrophages, analysis of adult tissues
was therefore considered uninformative. To exclude the contri-
bution of definitive hematopoiesis as the source of adult tissue-
resident macrophages, the authors used constitutively active
Flt3-cre fate mapping mice because YS hematopoiesis, unlike
definitive hematopoiesis, is not marked in this system. Although
the Flt3-cre approach marks adult HSC progenies robustly, fetal
HSC output is labeled relatively weakly, as also shown byGomez
Perdiguero et al. (2015). It is these same fetal HSCs and their
progenies that became labeled in our system and which we
claim to become a source of adult tissue-resident macrophages.
Therefore, the absence of label in adult tissue-resident macro-
phages of Flt3-cre mice does not argue strongly against the
contribution of fetal HSCs and their progenies. Our results
are in good agreement with those obtained in their elegant
Tie2MercreMer fate mapping mice, the major difference being that
even earlier precursors are tagged in the Tie2MercreMer system.
Our staggered tamoxifen pulses at later time points during
embryogenesis (E11.5, 13.5, 15.5, or 17.5) revealed individual
recruitment windows for tissue-resident macrophages, during
which the receiving tissues accepted newcomers, followed byImmunity 43, 382–393, August 18, 2015 ª2015 Elsevier Inc. 391
characteristic shut-off times for further recruitment. The micro-
glia compartment was already closed at E11.5 and no labeled
cells could be detected in adult microglia after the E11.5 pulse,
consistent with previous studies (Ginhoux et al., 2010; Gomez
Perdiguero et al., 2015). This also reflects our finding that the mi-
croglia is the only tissue that is solely derived from YS precursors
under normal steady-state conditions. All other adult tissue-resi-
dent macrophages shared a similar robust labeling index with
peripheral blood neutrophils and lymphocytes after the E11.5
pulse, i.e., they all share a source-definitive hematopoiesis. Dif-
ferences in tissue recruitment characteristics started to appear
with later embryonal pulses. Some tissues (as discussed above)
did not shut off and continuously recruited new precursors (co-
lon, peritoneal, and dermal MHC IIhi macrophages). Recruitment
of tissue-resident macrophages of the kidney and the dermal
MHC IIlo population occurred mainly during embryogenesis but
continued at low level during the adult stage. The liver, lung,
and spleen completely stopped recruiting new Kuppfer cells,
alveolar macrophages, and red pulpmacrophages, respectively,
during embryogenesis (between E15.5–17.5) and from then on
these tissues maintained their populations autonomously in
steady-state conditions as observed for microglia.
Epidermal LCs are an exception as a result of their hybrid
origins from YS and HSC waves. This raises the question of
whether functional specializations exist between LCs of different
origins, although current research seems to strongly suggest
that the tissue niche is able to induce proper functional charac-
teristics in the migrants regardless of their origins (Gentek
et al., 2014; Lavin et al., 2014; Suzuki et al., 2014).
It would be particularly interesting to determine the functional
consequences of an exchange of fully YS-derived microglia with
one dominated by cells of adult monocyte origin, a situation that
can arise after therapeutic or inflammatory perturbations.EXPERIMENTAL PROCEDURES
Animals
KitMercreMer mice were generated in our laboratory. Briefly, a codon-optimized
IRES-Mer-cre-Mer (Verrou et al., 1999) gene fusion was inserted into the
30 untranslated region (20 bp after the stop codon) of the Kit gene in BALB/c
embryonic stem cells (ESCs). Targeted ESCs were injected into C57BL/6 blas-
tocysts and the chimeric mice generated were then backcrossed to BALB/c
mice to transmit the KitMercreMer allele.
Cx3cr1-GFP and Rosa26LSL-eYFP transgenic mice were kindly provided by
Florent Ginhoux (SIgN, A*Star, Singapore). KitMercreMer mice were mated with
Rosa26LSL-eYFP generating (BALB/c 3 C57BL/6) F1 background mice that
were then used in all experiments. Timing of embryonic development was
estimated from the day of coitus, assuming vaginal plug formation as E0.5.
All transgenic mice were bred in the specific pathogen-free NTU animal
facility. This study followed the National Advisory Committee for Laboratory
Animal Research guidelines under the Animal & Birds (Care andUse of Animals
for Scientific Purposes) Rules of Singapore. The protocol was approved by the
by the Institutional Animal Care and Use Committee (IACUC) of the Nanyang
Technological University of Singapore.
Isolation of Tissue Samples and Flow Cytometry
Blood samples were taken from the mice via the retro-orbital vein under
anesthesia. BM cells were flushed out with PBS plus 2% fetal bovine serum.
To obtain bronchoalveolar lavage (BAL), we injected 2 ml PBS and then
retrieved through the trachea using a cannula.
For isolation of tissue macrophages, a protocol adapted from a previous
study was followed (Purnama et al., 2014). Briefly, 10 mL of PBS were used392 Immunity 43, 382–393, August 18, 2015 ª2015 Elsevier Inc.to perfuse the mice after CO2 euthanasia and tissues were dissected out
and minced followed by 30–60 min incubation at 37C with 100 mg/mL Colla-
genase (Roche Applied Science, Basel Switzerland,) and 20 Units/mL DNase I
(Life Technologies). To prepare single cells, tissue suspensions were passed
through a 19-gauge syringe. Leukocytes were enriched using a Percoll
gradient (GE Healthcare, Life Sciences). Single-cell suspensions were stained
and then analyzed using a LSRII flow cytometer (Becton Dickinson). Data were
analyzed with FlowJo software (TreeStar). The following antibodies were
used: CD11c (clone: N418), CD19 (clone: 6D5), GR-1 (clone: RB6-8C5),
CD11b (clone: M1/70), CD45 (clone: 30F11), Ly6C (HK1.4), Ly6G (clone:
1A8), EMR1 (also known as F4/80) (clone: BM8), CD64 (clone:X54-5/7.1),
CD16/32 (clone:93), MHC II (clone: M5/114.15.2), CD117 (clone: 2B8), EpCAM
(clone: G8.8), and CCR3 (clone: J073E5) all from BioLegend. Siglec-F (clone:
E50-2400) was purchased from BD Biosciences. MerTK (clone: BAF591)
was purchased from R&D Systems.
Induction of Cell Tagging with Tamoxifen and Isolation of Fetal
Tissues
Tamoxifen (Sigma) was dissolved in corn oil (Sigma). Four mg per mouse
of tamoxifen was administered by gavage for adult fate mapping or by
intraperitoneal injection in pregnant mothers for embryo labeling. For a single
tamoxifen pulse at adults, 16 mg was administered by gavage.
To harvest embryos at different time points, we euthanized pregnant female
mice by carbon dioxide asphyxiation. Uterine horns were taken out from
abdomen and embryos were harvested. Endometrial tissue and placenta
around each embryo proper were removed under the microscope without
puncturing YS. YS was then gently teased away from the embryo and FL
was dissected out using forceps. To isolate AGM, upper and lower portions
of the embryo were cut away from the embryo using fine needles. Extra tissue
at dorsal and ventral was cut away without damaging the aorta. YS, FL, and
AGM were then minced and digested the same way as adult tissues to get
single cell suspensions.
Giemsa Staining
Giemsa staining solution (Sigma) was used according to the manufacturer’s
instructions.
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